Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Exchange Traded Product
-
Shares outstanding
-
778K
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
477K
-
Shares change
-
-182K
-
Total reported value, excl. options
-
$14.5M
-
Value change
-
-$5.54M
-
Number of buys
-
12
-
Number of sells
-
-5
-
Price
-
$30.43
Significant Holders of FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product (XIDE) as of Q2 2024
19 filings reported holding XIDE - FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product as of Q2 2024.
FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product (XIDE) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 477K shares
of 778K outstanding shares and own 61.31% of the company stock.
Largest 10 shareholders include Sequent Planning LLC (176K shares), Foundations Investment Advisors, LLC (77.1K shares), Cetera Investment Advisers (47.1K shares), Accel Wealth Management (29.8K shares), COMMONWEALTH EQUITY SERVICES, LLC (23.5K shares), OSAIC HOLDINGS, INC. (21.4K shares), WORLD EQUITY GROUP, INC. (20.4K shares), JANE STREET GROUP, LLC (15.3K shares), FSB PREMIER WEALTH MANAGEMENT, INC. (12.2K shares), and Grant Street Asset Management, Inc. (9.87K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.